Contact
searchSearch
HMP Global

SmartTrak x Wound Care Collaboration News

News
Imbed Biosciences
03/20/2025
Imbed Bio was granted IDE (Investigational Device Exemption) clearance for human testing of a synthetic matrix with gallium-silver ions designed to treat biofilm formation for normal wound healing.
Imbed Bio was granted IDE (Investigational Device Exemption) clearance for human testing of a synthetic matrix with gallium-silver ions designed to treat biofilm formation for normal wound healing.
Imbed Bio was granted IDE...
03/20/2025
Wounds
News
Organogenesis
03/20/2025
The interim analysis for the PuraPly AM clinical trial is expected in Q425 and will be published in Q126. After publication, it is hoped that PuraPly AM can be evaluated for coverage in the LCD. ORGO Q424 Earnings Transcripatiento onSeeking...
The interim analysis for the PuraPly AM clinical trial is expected in Q425 and will be published in Q126. After publication, it is hoped that PuraPly AM can be evaluated for coverage in the LCD. ORGO Q424 Earnings Transcripatiento onSeeking...
The interim analysis for the...
03/20/2025
Wounds
News
National Chronic Wound Registry
03/20/2025
In Singapore, data collected on chronic wounds and outcomes for a national wound registry from 812 patients found 20% were recurrent with VLUs, the highest at 30% over 6 months. The development of a national wound registry is both feasible...
In Singapore, data collected on chronic wounds and outcomes for a national wound registry from 812 patients found 20% were recurrent with VLUs, the highest at 30% over 6 months. The development of a national wound registry is both feasible...
In Singapore, data collected on...
03/20/2025
Wounds
News
Convatec
03/20/2025
Convatec reported that they are on-track to obtain EU regulatory approval for ConvaNiox, the new brand for their nitric oxide dressing. Approval is expected in H125, with product launch in 2026. CTEC FY24 Earnings Report
Convatec reported that they are on-track to obtain EU regulatory approval for ConvaNiox, the new brand for their nitric oxide dressing. Approval is expected in H125, with product launch in 2026. CTEC FY24 Earnings Report
Convatec reported that they are...
03/20/2025
Wounds
News
Smith+Nephew
03/20/2025
SNN’s Allevyn Life Sacrum Foam Dressing received “favorable” Evidence Bar ratings from ECRI for pressure injury prevention. ECRI is an independent and non-profit organization striving to improve the safety, quality and cost-effectiveness of...
SNN’s Allevyn Life Sacrum Foam Dressing received “favorable” Evidence Bar ratings from ECRI for pressure injury prevention. ECRI is an independent and non-profit organization striving to improve the safety, quality and cost-effectiveness of...
SNN’s Allevyn Life Sacrum Foam...
03/20/2025
Wounds
News
VHT - Vaporox, Inc
03/20/2025
A retrospective analysis of 40 chronic wound patients who received vaporous hyperoxia therapy (VHT) was published, showing 62% healing at 16 wks, including 74% of DFUs. VHT was shown to accelerate healing in wounds also treated with skin...
A retrospective analysis of 40 chronic wound patients who received vaporous hyperoxia therapy (VHT) was published, showing 62% healing at 16 wks, including 74% of DFUs. VHT was shown to accelerate healing in wounds also treated with skin...
A retrospective analysis of 40...
03/20/2025
Wounds
News
Aquacel Ag - Convatec
03/20/2025
SmartTRAK noted a 203-patient study finding CISEB dressing (Aquacel Ag+ Extra/Aquacel Ag Advantage) more effective than DACC (Cutimed Sorbact) for hard-to-heal VLUs, with a 35% higher likelihood of complete wound closure and faster...
SmartTRAK noted a 203-patient study finding CISEB dressing (Aquacel Ag+ Extra/Aquacel Ag Advantage) more effective than DACC (Cutimed Sorbact) for hard-to-heal VLUs, with a 35% higher likelihood of complete wound closure and faster...
SmartTRAK noted a 203-patient...
03/20/2025
Wounds
News
NexoBrid - MediWound
03/20/2025
MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the...
03/20/2025
Wounds
News
NPseal - Guard Medical
03/20/2025
A study of 40 patients with 80 incisions received NPseals on one incision vs standard dressing on the other found that overall scores for scar spread, erythema, dyspigmentation, scar hypertrophy and overall impression were lower in the study...
A study of 40 patients with 80 incisions received NPseals on one incision vs standard dressing on the other found that overall scores for scar spread, erythema, dyspigmentation, scar hypertrophy and overall impression were lower in the study...
A study of 40 patients with 80...
03/20/2025
Wounds
News
SkinTE - PolarityTE
03/20/2025
Polarity announces SkinTE has received Breakthrough Therapy Designation (BTD) from the FDA for the treatment of Wagner Grade 1 DFUs based on key positive data from its Phase II study. The designation provides access to expedited development...
Polarity announces SkinTE has received Breakthrough Therapy Designation (BTD) from the FDA for the treatment of Wagner Grade 1 DFUs based on key positive data from its Phase II study. The designation provides access to expedited development...
Polarity announces SkinTE has...
03/20/2025
Wounds

Sign Up Today

Wounds Newsletter

Supplements

wounds
Supplement
SAWC Fall 2024 Abstract Proceedings
The Symposium on Advanced Wound Care (SAWC) Fall, October 2-5, 2024, received record-breaking abstract submission numbers. For additional conference coverage from SAWC Fall 2024, read more than 100 pages of scientific abstracts in the November supplement to Wounds.
Supplement
The Economic and Quality Effects of Wound Cleansing With Pure Hypochlorous Acid: Evidence-Based Evaluation and Clinical Experience
NovoSorb BTM (Biodegradable Temporizing Matrix) Clinical Compendium
Supplement
NovoSorb BTM (Biodegradable Temporizing Matrix) Clinical Compendium
Over the last 5 years, there has been exponential growth of clinical investigations and evidence shown of NovoSorb® BTM.
Preview image
White Papers
VERSAJET System: Precision Excision
Supplement
Venous Leg Ulcer Supplement to Wounds: May 2023

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use